Added to YB: 2026-05-12
Pitch date: 2026-05-10
INGN [neutral]
Inogen, Inc.
-4.75%
current return
Author Info
No bio for this author
Company Info
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally.
Market Cap
$191.8M
Pitch Price
$6.95
Price Target
N/A
Dividend
N/A
EV/EBITDA
-16.87
P/E
-7.65
EV/Sales
0.28
Sector
Health Care Equipment and Supplies
Category
growth
Q1 Earnings Wire May 8, 2026 PM Drop - Inogen, Inc.
INGN (earnings): Q1 rev $85.1M (+3.4% YoY) beat guide; FY26 reiterated $366-373M (~6% growth). Adj EBITDA -$1.4M (vs +$0.04M prior yr) on R&D spend. $30M buyback auth, $1.9M deployed Q1. $111.5M cash, zero debt. Aurora CPAP launched US (OSA entry), Rove 6 in Brazil. New CFO/CMO. Stock faded on EBITDA miss despite rev beat.
Read full article (1 min)